Biotech’s top 10 money raisers of 2018
2017 was a big year for biotech venture capital, and 2018 managed to top it. Last year, private biotech companies raised a total of $16.8B, beating 2017’s then-record $12.1B by 39%! In 2018, the average per financing round increased too, as well as the proportion of enormous megarounds. Check out the list of biotech’s top 10 money raisers of 2018:
- Moderna Therapeutics
- Samumed
- Relay Therapeutics
- Cerevel Therapeutics
- Allogene Therapeutics
- BioNTech
- CStone Pharmaceuticals
- Brii Biosciences
- Celularity
- Viela Bio